Elkhoury Fuad F, Rambhatla Amarnath, Mills Jesse N, Rajfer Jacob
Department of Urology, David Geffen School of Medicine at UCLA, Los Angeles, CA.
Department of Urology, University Health Center, Wayne State University, Detroit, MI.
Urology. 2017 Dec;110:1-8. doi: 10.1016/j.urology.2017.07.030. Epub 2017 Jul 31.
Erectile dysfunction and cardiovascular disease share a similar underlying pathophysiology, and low serum testosterone, known as hypogonadism, is a significant player in both conditions. Hypogonadism is a known risk factor for cardiovascular events and worsened mortality, thus influencing physicians to recommend testosterone replacement in hypogonadal men. However, at least 4 recent reports suggest that testosterone replacement may worsen cardiovascular risk, heightening hesitancy in the medical community to treat patients with hypogonadism with testosterone. This review highlights the triad of cardiovascular disease, erectile dysfunction, and testosterone therapy and provides the physician with some guiding principles for navigating these recent concerns.
勃起功能障碍和心血管疾病有着相似的潜在病理生理学机制,而血清睾酮水平低(即性腺功能减退)在这两种病症中都起着重要作用。性腺功能减退是心血管事件和死亡率恶化的已知危险因素,因此促使医生建议对性腺功能减退的男性进行睾酮替代治疗。然而,最近至少有4份报告表明,睾酮替代治疗可能会增加心血管疾病风险,这使得医学界在使用睾酮治疗性腺功能减退患者时更加犹豫不决。这篇综述重点介绍了心血管疾病、勃起功能障碍和睾酮治疗这三者之间的关系,并为医生应对这些近期备受关注的问题提供了一些指导原则。